Since ASPP2 mRNA expression associated with risk subgroups in patients with acute leukemia (Figure 1), we wished to examine ASPP2 protein expression in patient-derived primary leukemic blasts using our flow cytometry-based method (Figure 3). This evidence concerns the gene TP53BP2 and acute leukemia.